Valuation
- Market cap
- 178,840,000
- Revenue TTM
- $0
- Net income TTM
- $-12,200,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 629,100
- Avg volume
- 888,912
- Day's range
- $4.36 – $4.80
- Shares out
- 37,730,000
- Stochastic %K
- 60%
- Beta
- 1.43
- Analysts
- —
- Price target
- $17.00
Company profile
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 an...
Show more
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 732 889 3111
- Website
- https://www.tharimmune.com
- Address
- 34 Shrewsbury Avenue, Suite 1C, Red Bank, United States
Latest news
No headlines yet.
